人気ポスト

In this study of patients with lupus and type 2 diabetes, SGLT2 inhibitor use was associated with a lower risk of lupus nephritis, dialysis, heart failure, and all-cause mortality. https://t.co/M91VSNZLew

メニューを開く

JAMA Network Open@JAMANetworkOpen

ほかの人気ポスト

もっと見る
Yahoo!リアルタイム検索アプリ